Trial intelligence / Profile preview

Cipepofol vs Propofol for Induction of General Anesthesia in Pediatric Surgery

NCT07510945Phase 3Not yet recruiting

Sponsor
Haisco Pharmaceutical Group Co., Ltd.
Start
May 2026
Primary completion
May 2028
Modality
Allosteric Modulators
01

Overview

A Phase 3 trial of cipepofol in general anesthesia, sponsored by Haisco Pharmaceutical Group Co., Ltd.. Planned start May 2026; status: not yet recruiting.

02

Drugs

cipepofol
03

Conditions

general anesthesia

Beyond the preview

Go deeper on NCT07510945.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07510945.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call